Rubric Capital Management LP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-31 11:08 am Unchanged |
2023-11-14 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 26,713,503 17.700% |
0 (Unchanged) |
Filing |
| 2023-07-25 4:13 pm Purchase |
2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 26,713,503 19.000% |
14,963,503 (+127.35%) |
Filing |
| 2023-02-22 4:24 pm Unchanged |
2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 11,750,000 9.900% |
0 (Unchanged) |
Filing |
| 2023-02-06 09:00 am Purchase |
2023-01-25 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 11,750,000 9.900% |
11,750,000 (New Position) |
Filing |